QQQ   315.39 (-2.70%)
AAPL   122.34 (-2.40%)
MSFT   230.71 (-1.64%)
FB   257.30 (-2.65%)
GOOGL   2,028.24 (-2.67%)
AMZN   3,083.60 (-2.40%)
TSLA   696.97 (-6.07%)
NVDA   538.02 (-7.23%)
BABA   243.60 (-2.69%)
CGC   33.85 (-4.92%)
GE   12.83 (-2.21%)
MU   89.91 (-2.82%)
NIO   47.90 (-7.64%)
AMD   83.17 (-4.34%)
T   28.72 (-2.25%)
F   11.92 (-2.85%)
ACB   11.09 (-4.73%)
DIS   193.20 (-2.18%)
BA   219.90 (-4.12%)
NFLX   541.13 (-2.22%)
BAC   36.18 (-0.55%)
QQQ   315.39 (-2.70%)
AAPL   122.34 (-2.40%)
MSFT   230.71 (-1.64%)
FB   257.30 (-2.65%)
GOOGL   2,028.24 (-2.67%)
AMZN   3,083.60 (-2.40%)
TSLA   696.97 (-6.07%)
NVDA   538.02 (-7.23%)
BABA   243.60 (-2.69%)
CGC   33.85 (-4.92%)
GE   12.83 (-2.21%)
MU   89.91 (-2.82%)
NIO   47.90 (-7.64%)
AMD   83.17 (-4.34%)
T   28.72 (-2.25%)
F   11.92 (-2.85%)
ACB   11.09 (-4.73%)
DIS   193.20 (-2.18%)
BA   219.90 (-4.12%)
NFLX   541.13 (-2.22%)
BAC   36.18 (-0.55%)
QQQ   315.39 (-2.70%)
AAPL   122.34 (-2.40%)
MSFT   230.71 (-1.64%)
FB   257.30 (-2.65%)
GOOGL   2,028.24 (-2.67%)
AMZN   3,083.60 (-2.40%)
TSLA   696.97 (-6.07%)
NVDA   538.02 (-7.23%)
BABA   243.60 (-2.69%)
CGC   33.85 (-4.92%)
GE   12.83 (-2.21%)
MU   89.91 (-2.82%)
NIO   47.90 (-7.64%)
AMD   83.17 (-4.34%)
T   28.72 (-2.25%)
F   11.92 (-2.85%)
ACB   11.09 (-4.73%)
DIS   193.20 (-2.18%)
BA   219.90 (-4.12%)
NFLX   541.13 (-2.22%)
BAC   36.18 (-0.55%)
QQQ   315.39 (-2.70%)
AAPL   122.34 (-2.40%)
MSFT   230.71 (-1.64%)
FB   257.30 (-2.65%)
GOOGL   2,028.24 (-2.67%)
AMZN   3,083.60 (-2.40%)
TSLA   696.97 (-6.07%)
NVDA   538.02 (-7.23%)
BABA   243.60 (-2.69%)
CGC   33.85 (-4.92%)
GE   12.83 (-2.21%)
MU   89.91 (-2.82%)
NIO   47.90 (-7.64%)
AMD   83.17 (-4.34%)
T   28.72 (-2.25%)
F   11.92 (-2.85%)
ACB   11.09 (-4.73%)
DIS   193.20 (-2.18%)
BA   219.90 (-4.12%)
NFLX   541.13 (-2.22%)
BAC   36.18 (-0.55%)
Log in
NASDAQ:FULC

Fulcrum Therapeutics Price Target, Predictions & Analyst Ratings

$13.11
-0.92 (-6.56 %)
(As of 02/25/2021 02:41 PM ET)
Add
Compare
Today's Range
$13.11
Now: $13.11
$13.80
50-Day Range
$10.98
MA: $12.50
$15.32
52-Week Range
$7.01
Now: $13.11
$22.39
Volume1,398 shs
Average Volume172,307 shs
Market Capitalization$428.26 million
P/E RatioN/A
Dividend YieldN/A
Beta0.94

Analyst Ratings

Fulcrum Therapeutics (NASDAQ:FULC) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Fulcrum Therapeutics in the last 12 months. Their average twelve-month price target is $18.17, predicting that the stock has a possible upside of 38.57%. The high price target for FULC is $23.00 and the low price target for FULC is $11.00. There are currently 1 sell rating, 1 hold rating and 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
FULC Consensus Rating: BuyBuyBuyHold
FULC Consensus Rating Score: 2.572.572.572.40
FULC Analyst Ratings: 1 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
FULC Consensus Price Target: $18.17$18.17$18.17$16.00
FULC Price Target Upside: 38.57% upside83.97% upside83.97% upside63.31% upside

Fulcrum Therapeutics (NASDAQ:FULC) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Fulcrum Therapeutics (NASDAQ:FULC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/10/2020SVB LeerinkLower Price TargetOutperform$25.00 ➝ $23.00High
10/15/2020Piper SandlerInitiated CoverageOverweight$22.00Medium
8/12/2020BTIG ResearchLower Price Target$27.00 ➝ $22.00High
8/12/2020Bank of AmericaDowngradeNeutral ➝ Underperform$11.00High
8/12/2020HC WainwrightLower Price TargetBuy$28.00 ➝ $20.00High
8/12/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight$29.00 ➝ $11.00High
6/17/2020Raymond JamesUpgradeMarket Perform ➝ OutperformHigh
(Data available from 2/25/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.